<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Vasc Health Risk Manag</journal-id><journal-id journal-id-type="publisher-id">Vascular Health and Risk Management</journal-id><journal-title-group><journal-title>Vascular Health and Risk Management</journal-title></journal-title-group><issn pub-type="ppub">1176-6344</issn><issn pub-type="epub">1178-2048</issn><publisher><publisher-name>Dove Medical Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">19774216</article-id><article-id pub-id-type="publisher-id">vhrm-5-751</article-id><article-categories><subj-group subj-group-type="heading"><subject>Short Report</subject></subj-group></article-categories><title-group><article-title>HbA<sub>1c</sub> is associated with severity of obstructive sleep apnea hypopnea syndrome in nondiabetic men</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Papanas</surname><given-names>Nikolaos</given-names></name><xref ref-type="aff" rid="af1-vhrm-5-751">1</xref><xref ref-type="corresp" rid="c1-vhrm-5-751"/></contrib><contrib contrib-type="author"><name><surname>Steiropoulos</surname><given-names>Paschalis</given-names></name><xref ref-type="aff" rid="af2-vhrm-5-751">2</xref></contrib><contrib contrib-type="author"><name><surname>Nena</surname><given-names>Evangelia</given-names></name><xref ref-type="aff" rid="af2-vhrm-5-751">2</xref></contrib><contrib contrib-type="author"><name><surname>Tzouvelekis</surname><given-names>Argyris</given-names></name><xref ref-type="aff" rid="af2-vhrm-5-751">2</xref></contrib><contrib contrib-type="author"><name><surname>Maltezos</surname><given-names>Efstratios</given-names></name><xref ref-type="aff" rid="af1-vhrm-5-751">1</xref></contrib><contrib contrib-type="author"><name><surname>Trakada</surname><given-names>Georgia</given-names></name><xref ref-type="aff" rid="af2-vhrm-5-751">2</xref></contrib><contrib contrib-type="author"><name><surname>Bouros</surname><given-names>Demosthenes</given-names></name><xref ref-type="aff" rid="af2-vhrm-5-751">2</xref></contrib></contrib-group><aff id="af1-vhrm-5-751"><label>1</label> Outpatient Clinic of Obesity, Diabetes and Metabolism at the 2nd Department of Internal Medicine</aff><aff id="af2-vhrm-5-751"><label>2</label> Department of Pneumonology, Democritus University of Thrace, Alexandroupolis, Greece</aff><author-notes><corresp id="c1-vhrm-5-751">Correspondence: Nikolaos Papanas, Democritus University of Thrace, G Kondyli 22, Alexandroupolis 68100, Greece, Tel +30 69 7754 4337, Fax +30 25 5107 4723, Email <email>papanasnikos@yahoo.gr</email></corresp></author-notes><pub-date pub-type="collection"><year>2009</year></pub-date><!--Dove Press titles changed from ppub to collections in 2009. Fake ppub written to satisfy Coll Date Type=ppub--><pub-date pub-type="ppub"><year>2009</year></pub-date><pub-date pub-type="epub"><day>18</day><month>9</month><year>2009</year></pub-date><volume>5</volume><fpage>751</fpage><lpage>756</lpage><permissions><copyright-statement>&#x000a9; 2009 Papanas et al, publisher and licensee Dove Medical Press Ltd.</copyright-statement><license><license-p>This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.</license-p></license></permissions><abstract><p>The aim of this study was to examine the potential correlation of sleep characteristics with glucose metabolism in nondiabetic men with obstructive sleep apnea syndrome (OSAS). Included were 31 male patients (mean age 46.7 &#x000b1;11 years), recently diagnosed with OSAS by full polysomnography. There was a significant correlation of fasting glucose and glycosylated hemoglobin (HbA<sub>1c</sub>) levels with arousal index (<italic>P</italic> = 0.047 and <italic>P</italic> =0.014, respectively). Moreover, HbA<sub>1c</sub> levels were correlated with apnea hypopnea index (<italic>P</italic> =0.009), a widely accepted marker of the severity of OSAS, and with percentage of sleep time with saturation of hemoglobin with oxygen as measured by pulse oximetry (SpO<sub>2</sub>) &#x0003c; 90% (t &#x0003c; 90%) ( <italic>P</italic> =0.010). Finally, glucose and HbA<sub>1c</sub> levels showed a significant negative correlation with average SpO<sub>2</sub> (<italic>P</italic> =0.013 and <italic>P</italic> = 0.012, respectively) and, additionally, glucose levels with minimum SpO <sub>2</sub> (<italic>P</italic> =0.027) during sleep. In conclusion, severity of OSAS among nondiabetic men is associated with increased HbA<sub>1c</sub> levels and increased fasting glucose. Thus, severity of OSAS may be an additional marker of cardiovascular risk, as well as of future diabetes, in these subjects. However, further work is needed to confirm the clinical significance of these observations.</p></abstract><kwd-group><kwd>obstructive sleep apnea syndrome</kwd><kwd>glucose metabolism</kwd><kwd>glycated hemoglobin</kwd><kwd>sleep disordered breathing</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Obstructive sleep apnea syndrome (OSAS), a common disorder, affecting approximately 3%&#x02013;7% of adult men and 2%&#x02013;5% of adult women in the general population,<xref ref-type="bibr" rid="b1-vhrm-5-751">1</xref> is being increasingly recognized as an important cause of morbidity and mortality.<xref ref-type="bibr" rid="b2-vhrm-5-751">2</xref> This clinical condition is characterized by repeated episodes of complete or partial obstruction of the upper airway during sleep, associated with increased respiratory efforts, intermittent arterial oxygen desaturation, systemic and pulmonary arterial blood pressure alterations and sleep fragmentation. The cardinal symptoms of OSAS are nocturnal respiratory pauses, interrupted by loud snoring, and excessive daytime sleepiness.<xref ref-type="bibr" rid="b2-vhrm-5-751">2</xref></p><p>OSAS and type 2 diabetes mellitus (DM) are common comorbid conditions. Indeed, the prevalence of OSAS is estimated to be between 18% and 36% in subjects with type 2 DM.<xref ref-type="bibr" rid="b3-vhrm-5-751">3</xref>,<xref ref-type="bibr" rid="b4-vhrm-5-751">4</xref> Vice versa, the prevalence of type 2 DM is approximately 30% in OSAS patients.<xref ref-type="bibr" rid="b5-vhrm-5-751">5</xref> Several lines of evidence suggest an independent association of OSAS with insulin resistance and DM.<xref ref-type="bibr" rid="b6-vhrm-5-751">6</xref>&#x02013;<xref ref-type="bibr" rid="b9-vhrm-5-751">9</xref></p><p>Ip and colleagues reported that markers of OSAS severity (Apnea Hypopnea Index [AHI] and minimum oxygen saturation) were associated with insulin resistance,<xref ref-type="bibr" rid="b6-vhrm-5-751">6</xref> while Punjabi and colleagues found that sleep-disordered breathing (SDB) was associated with insulin resistance in mildly obese but otherwise healthy males from the general population.<xref ref-type="bibr" rid="b7-vhrm-5-751">7</xref> Cross-sectional data from the Sleep Heart Health Study and the Wisconsin Sleep Cohort found similar results in population cohorts.<xref ref-type="bibr" rid="b8-vhrm-5-751">8</xref>,<xref ref-type="bibr" rid="b9-vhrm-5-751">9</xref> However, the longitudinal data from the Wisconsin Cohort could not demonstrate a clear relationship between SDB and the subsequent development of DM.<xref ref-type="bibr" rid="b9-vhrm-5-751">9</xref> Other studies in snorers have confirmed the association of SDB and insulin resistance or diabetes in nonobese Korean and Indian males,<xref ref-type="bibr" rid="b10-vhrm-5-751">10</xref>,<xref ref-type="bibr" rid="b11-vhrm-5-751">11</xref> and similar results were found in subjects with suspected OSAS.<xref ref-type="bibr" rid="b5-vhrm-5-751">5</xref>,<xref ref-type="bibr" rid="b12-vhrm-5-751">12</xref>,<xref ref-type="bibr" rid="b13-vhrm-5-751">13</xref> In all reports, the association was independent of obesity, even though obesity is known to increase the risk for impaired glucose tolerance. In normal subjects, hypoxia appears to be an important contributor to glucose intolerance.<xref ref-type="bibr" rid="b14-vhrm-5-751">14</xref> Recent state-of-the art reviews have emphasized the need for further clinical research in this direction.<xref ref-type="bibr" rid="b15-vhrm-5-751">15</xref>,<xref ref-type="bibr" rid="b16-vhrm-5-751">16</xref></p><p>Little is known so far on the association between glycemic profile and severity of OSAS in patients that do not meet the criteria for the diagnosis of diabetes. Thus, the aim of the present study was to examine the potential correlation of sleep characteristics with glucose metabolism in nondiabetic men with OSAS.</p></sec><sec sec-type="materials|methods"><title>Materials and methods</title><sec sec-type="methods"><title>Study group</title><p>Thirty one consecutive male patients, with recently diagnosed OSAS (AHI &#x0003e; 15/hour) by polysomnography between January and June 2009, comprised the study group. Each participant was evaluated by full clinical examination and completed a detailed questionnaire about sleep habits. Exclusion criteria were: known diabetes mellitus or fasting glycemia (fasting glucose &#x02265; 126 mg/dl or glycosylated hemoglobin [HbA<sub>1c</sub>]&#x0003e; 6.5%),<xref ref-type="bibr" rid="b17-vhrm-5-751">17</xref> current smoking, cardiovascular or cerebrovascular disease, hypertension or other chronic disease, systemic medication use, as well as previous diagnosis/treatment for OSAS. The study was approved by the Institutional Ethics Committee and all subjects gave written informed consent.</p></sec><sec><title>Polysomnography</title><p>Each subject underwent standard full night polysomnography (PSG). Sleep records were manually scored, according to standardized criteria.<xref ref-type="bibr" rid="b18-vhrm-5-751">18</xref> AHI was defined as the total number of apneas and hypopneas per hour of electroencephalographic sleep. Arousal Index (AI) was the total number of arousals per hour of recorded sleep. OSAS was defined as an AHI of &#x02265; 15/hour.</p></sec><sec><title>Blood assays</title><p>Fasting venous blood samples were collected the day after PSG, between 8 and 9 AM, after an overnight fast. Biochemical analyses were performed in an ILAB 600 analyzer (Biochem, Tokyo, Japan) with enzymatic method for glucose (mg/dL) while HbA<sub>1c</sub> was measured by high-performance liquid chromatography (Adams A<sub>1c</sub> HA-8160; Arkray, Kyoto, Japan).</p></sec><sec sec-type="methods"><title>Statistical analysis</title><p>Analysis was performed with SPSS for Windows, version 15.0 (SPSS, Chicago, IL, USA). Normality was examined by the Kolmogorov-Smirnoff test. Descriptive results for continuous variables are expressed as mean &#x000b1;SD. Regression analysis was applied to explore relationships between glucose or HbA<sub>1c</sub> values and apnea-related characteristics, independently of body mass index (BMI). Statistical significance was defined at a level of 5% (<italic>P</italic> &#x0003c; 0.05).</p></sec></sec><sec sec-type="results"><title>Results</title><p>Mean age was 46.7 &#x000b1;11 years (ranging between 28&#x02013;71 years) and mean BMI was 34.8 &#x000b1;6.6 kg/m <sup>2</sup> (ranging between 28 and 54.9 Kg/m<sup>2</sup>). Neck circumference was 44.5 &#x000b1;2.8 cm while waist circumference was 119.9 &#x000b1;18.6 cm. Sleep and metabolic characteristics of patients are presented in <xref ref-type="table" rid="t1-vhrm-5-751">Table 1</xref>.</p><p>A significant correlation between HbA<sub>1c</sub> levels and apnea-related parameters (AHI, average saturation of hemoglobin with oxygen as measured by pulse oximetry [SpO<sub>2</sub>], percentage of sleep time with SpO<sub>2</sub> &#x0003c; 90%, ie, t &#x0003c; 90, and AI) was revealed (<xref ref-type="fig" rid="f1-vhrm-5-751">Figure 1</xref>). Moreover, fasting glucose levels were significantly correlated with AI and average and minimum SpO<sub>2</sub> (<xref ref-type="fig" rid="f2-vhrm-5-751">Figure 2</xref>). As shown in <xref ref-type="table" rid="t2-vhrm-5-751">Table 2</xref>, correlations were independent of BMI.</p></sec><sec sec-type="discussion"><title>Discussion</title><p>The present study examined the potential correlation of sleep characteristics with glucose metabolism in nondiabetic men with OSAS. Our results suggest that in nondiabetic male OSAS patients without comorbidities, the severity of OSAS (evaluated by the number of respiratory cessation events, the indices of hypoxemia during sleep and the arousal index) is associated with increased fasting glucose and HbA<sub>1c</sub> levels.</p><p>The novel association of HbA<sub>1c</sub> with severity of OSAS appears interesting, and may have important implications in clinical practice. Essentially, not only is HbA<sub>1c</sub> the major target for the prevention of complications in type 2 DM,<xref ref-type="bibr" rid="b19-vhrm-5-751">19</xref> but it also represents a significant risk marker for cardiovascular disease in the general population.<xref ref-type="bibr" rid="b20-vhrm-5-751">20</xref>&#x02013;<xref ref-type="bibr" rid="b22-vhrm-5-751">22</xref> It is, therefore, tempting to consider whether the severity of OSAS may be viewed as a risk marker for cardiovascular disease. This assumption enhances the increasing awareness that OSAS itself is a risk factor for cardiovascular morbidity.<xref ref-type="bibr" rid="b23-vhrm-5-751">23</xref> Equally importantly, HbA<sub>1c</sub> is being increasingly appreciated as a risk marker for the development of DM in the general population.<xref ref-type="bibr" rid="b24-vhrm-5-751">24</xref>,<xref ref-type="bibr" rid="b25-vhrm-5-751">25</xref> Hence, the severity of OSAS may be associated with increased risk for the development of DM. The utility of HbA<sub>1c</sub> in the prediction of diabetes in subjects with OSAS is plausible, given the association between these two conditions. However, the number of our patients is small, and further research is required to confirm our findings.</p><p>Similarly, a significant correlation was observed between fasting glucose levels and severity of nocturnal hypoxemia (evaluated by the average SpO<sub>2</sub> and the minimum SpO<sub>2</sub> during sleep). In view of the fact that the level of hyperglycemia is an established risk factor for both diabetes<xref ref-type="bibr" rid="b20-vhrm-5-751">20</xref>,<xref ref-type="bibr" rid="b25-vhrm-5-751">25</xref> and cardiovascular morbidity and mortality,<xref ref-type="bibr" rid="b20-vhrm-5-751">20</xref>,<xref ref-type="bibr" rid="b26-vhrm-5-751">26</xref>&#x02013;<xref ref-type="bibr" rid="b28-vhrm-5-751">28</xref> this association enhances the significance of the severity of OSAS as a risk factor for diabetes and vascular disease. While it is known that OSAS and impaired glucose homeostasis are interrelated,<xref ref-type="bibr" rid="b6-vhrm-5-751">6</xref>&#x02013;<xref ref-type="bibr" rid="b11-vhrm-5-751">11</xref> our dataset emphasizes the role of OSAS severity in putting otherwise healthy male patients at increased cardiovascular risk.</p><p>Both fasting glucose and HbA<sub>1c</sub> exhibited a significant correlation with AI. This finding indicates that the effect of OSAS on glycemic profile was, partly at least, mediated by sympathetic nervous system activation.<xref ref-type="bibr" rid="b1-vhrm-5-751">1</xref>,<xref ref-type="bibr" rid="b5-vhrm-5-751">5</xref> The latter is a recognized mechanism underlying the pathogenesis of insulin resistance and impaired glucose metabolism in OSAS patients.<xref ref-type="bibr" rid="b2-vhrm-5-751">2</xref>,<xref ref-type="bibr" rid="b5-vhrm-5-751">5</xref>&#x02013;<xref ref-type="bibr" rid="b8-vhrm-5-751">8</xref> Our data provide additional evidence for the potential role of sympathetic overactivity in the modification of hyperglycemia in otherwise healthy individuals with OSAS.</p><p>Finally, BMI did not correlate with HbA<sub>1c</sub> levels or glucose levels. Hence, OSAS severity was directly associated with impaired glucose metabolism independently of obesity. This result agrees with studies showing that SDB is associated with glucose intolerance and insulin resistance independently of BMI.<xref ref-type="bibr" rid="b8-vhrm-5-751">8</xref>,<xref ref-type="bibr" rid="b9-vhrm-5-751">9</xref>,<xref ref-type="bibr" rid="b12-vhrm-5-751">12</xref>,<xref ref-type="bibr" rid="b13-vhrm-5-751">13</xref> The role of SDB is enhanced by evidence showing that experimental hypoxia directly causes glucose intolerance.<xref ref-type="bibr" rid="b14-vhrm-5-751">14</xref> However, other workers advocate an important role for central obesity in impaired glucose metabolism, and so recent state-of-the art reviews highlight the need for further clarification.<xref ref-type="bibr" rid="b15-vhrm-5-751">15</xref>,<xref ref-type="bibr" rid="b16-vhrm-5-751">16</xref> In the type of subjects herein examined, OSAS severity appears to outweigh obesity, as demonstrated by its direct association with impaired glucose metabolism.</p><p>Notably, this study excluded women, in order to avoid potential discrepancies between the two genders. Indeed, there is evidence of a different effect of sleep apnea on metabolic profile and on inflammatory response in women, partly at least due to different hormonal regulation.<xref ref-type="bibr" rid="b1-vhrm-5-751">1</xref>,<xref ref-type="bibr" rid="b29-vhrm-5-751">29</xref> For this reason, the correlations found need to be investigated in women as well.</p><p>The limitations of the present report include the small number of patients and the cross-sectional design. Based on our findings, it is plausible to propose that risk factors for diabetes and vascular disease in otherwise healthy OSAS patients may be identified in association with OSAS severity. Nonetheless, there is no prospective data to confirm that this risk translates into worse outcome in actual clinical practice. Such follow-up was beyond the scope of this study, and further prospective research is needed to provide a definite answer.</p><p>In conclusion, among nondiabetic men with OSAS, the severity of this condition is associated with increased HbA<sub>1c</sub> levels and increased fasting glucose. Thus, the severity of OSAS may be an additional marker of cardiovascular risk as well as of future diabetes in these subjects. Nevertheless, the clinical significance of our observations remains to be confirmed by prospective studies.</p></sec></body><back><fn-group><fn><p><bold>Disclosures</bold></p><p>The authors report no conflicts of interest in this work.</p></fn></fn-group><ref-list><title>References</title><ref id="b1-vhrm-5-751"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Punjabi</surname><given-names>NM</given-names></name></person-group><article-title>The epidemiology of adult obstructive sleep apnea</article-title><source>Proc Am Thorac Soc</source><year>2008</year><volume>15</volume><issue>2</issue><fpage>136</fpage><lpage>143</lpage><pub-id pub-id-type="pmid">18250205</pub-id></mixed-citation></ref><ref id="b2-vhrm-5-751"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNicholas</surname><given-names>WT</given-names></name><name><surname>Bonsigore</surname><given-names>MR</given-names></name></person-group><article-title>Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities</article-title><source>Eur Respir J</source><year>2007</year><volume>29</volume><issue>1</issue><fpage>156</fpage><lpage>178</lpage><pub-id pub-id-type="pmid">17197482</pub-id></mixed-citation></ref><ref id="b3-vhrm-5-751"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>West</surname><given-names>SD</given-names></name><name><surname>Nicoll</surname><given-names>DJ</given-names></name><name><surname>Stradling</surname><given-names>JR</given-names></name></person-group><article-title>Prevalence of obstructive sleep apnoea in men with type 2 diabetes</article-title><source>Thorax</source><year>2006</year><volume>61</volume><issue>11</issue><fpage>945</fpage><lpage>950</lpage><pub-id pub-id-type="pmid">16928713</pub-id></mixed-citation></ref><ref id="b4-vhrm-5-751"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Einhorn</surname><given-names>D</given-names></name><name><surname>Stewart</surname><given-names>DA</given-names></name><name><surname>Erman</surname><given-names>MK</given-names></name><name><surname>Gordon</surname><given-names>N</given-names></name><name><surname>Philis-Tsimikas</surname><given-names>A</given-names></name><name><surname>Casal</surname><given-names>E</given-names></name></person-group><article-title>Prevalence of sleep apnea in a population of adults with type 2 diabetes mellitus</article-title><source>Endocr Pract</source><year>2007</year><volume>13</volume><issue>4</issue><fpage>355</fpage><lpage>362</lpage><pub-id pub-id-type="pmid">17669711</pub-id></mixed-citation></ref><ref id="b5-vhrm-5-751"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meslier</surname><given-names>N</given-names></name><name><surname>Gagnadoux</surname><given-names>F</given-names></name><name><surname>Giraud</surname><given-names>P</given-names></name><etal/></person-group><article-title>Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome</article-title><source>Eur Respir J</source><year>2003</year><volume>22</volume><issue>1</issue><fpage>156</fpage><lpage>160</lpage><pub-id pub-id-type="pmid">12882466</pub-id></mixed-citation></ref><ref id="b6-vhrm-5-751"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ip</surname><given-names>MS</given-names></name><name><surname>Lam</surname><given-names>B</given-names></name><name><surname>Ng</surname><given-names>MM</given-names></name><name><surname>Lam</surname><given-names>WK</given-names></name><name><surname>Tsang</surname><given-names>KW</given-names></name><name><surname>Lam</surname><given-names>KS</given-names></name></person-group><article-title>Obstructive sleep apnea is independently associated with insulin resistance</article-title><source>Am J Respir Crit Care Med</source><year>2002</year><volume>165</volume><issue>5</issue><fpage>670</fpage><lpage>676</lpage><pub-id pub-id-type="pmid">11874812</pub-id></mixed-citation></ref><ref id="b7-vhrm-5-751"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Punjabi</surname><given-names>NM</given-names></name><name><surname>Sorkin</surname><given-names>JD</given-names></name><name><surname>Katzel</surname><given-names>LI</given-names></name><name><surname>Goldberg</surname><given-names>AP</given-names></name><name><surname>Schwartz</surname><given-names>AR</given-names></name><name><surname>Smith</surname><given-names>PL</given-names></name></person-group><article-title>Sleep-disordered breathing and insulin resistance in middle-aged and overweight men</article-title><source>Am J Respir Crit Care Med</source><year>2002</year><volume>165</volume><issue>5</issue><fpage>677</fpage><lpage>682</lpage><pub-id pub-id-type="pmid">11874813</pub-id></mixed-citation></ref><ref id="b8-vhrm-5-751"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Punjabi</surname><given-names>NM</given-names></name><name><surname>Shahar</surname><given-names>E</given-names></name><name><surname>Redline</surname><given-names>S</given-names></name><name><surname>Gottlieb</surname><given-names>DJ</given-names></name><name><surname>Givelber</surname><given-names>R</given-names></name><name><surname>Resnick</surname><given-names>HE</given-names></name></person-group><article-title>Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study</article-title><source>Am J Epidemiol</source><year>2004</year><volume>160</volume><issue>6</issue><fpage>521</fpage><lpage>530</lpage><pub-id pub-id-type="pmid">15353412</pub-id></mixed-citation></ref><ref id="b9-vhrm-5-751"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reichmuth</surname><given-names>KJ</given-names></name><name><surname>Austin</surname><given-names>D</given-names></name><name><surname>Skatrud</surname><given-names>JB</given-names></name><name><surname>Young</surname><given-names>T</given-names></name></person-group><article-title>Association of sleep apnea and type II diabetes: a population-based study</article-title><source>Am J Respir Crit Care Med</source><year>2005</year><volume>172</volume><issue>12</issue><fpage>1590</fpage><lpage>1595</lpage><pub-id pub-id-type="pmid">16192452</pub-id></mixed-citation></ref><ref id="b10-vhrm-5-751"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>C</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><etal/></person-group><article-title>Association of habitual snoring with glucose and insulin metabolism in nonobese Korean adult men</article-title><source>Am J Respir Crit Care Med</source><year>2005</year><volume>171</volume><issue>3</issue><fpage>287</fpage><lpage>291</lpage><pub-id pub-id-type="pmid">15542791</pub-id></mixed-citation></ref><ref id="b11-vhrm-5-751"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Udwadia</surname><given-names>ZF</given-names></name><name><surname>Doshi</surname><given-names>AV</given-names></name><name><surname>Lonkar</surname><given-names>SG</given-names></name><name><surname>Singh</surname><given-names>CI</given-names></name></person-group><article-title>Prevalence of sleep-disordered breathing and sleep apnea in middle-aged urban Indian men</article-title><source>Am J Respir Crit Care Med</source><year>2004</year><volume>169</volume><issue>2</issue><fpage>168</fpage><lpage>173</lpage><pub-id pub-id-type="pmid">14604837</pub-id></mixed-citation></ref><ref id="b12-vhrm-5-751"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tassone</surname><given-names>F</given-names></name><name><surname>Lanfranco</surname><given-names>F</given-names></name><name><surname>Gianotti</surname><given-names>L</given-names></name><etal/></person-group><article-title>Obstructive sleep apnoea syndrome impairs insulin sensitivity independently of anthropometric variables</article-title><source>Clin Endocrinol (Oxf)</source><year>2003</year><volume>59</volume><issue>3</issue><fpage>374</fpage><lpage>379</lpage><pub-id pub-id-type="pmid">12919162</pub-id></mixed-citation></ref><ref id="b13-vhrm-5-751"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Makino</surname><given-names>S</given-names></name><name><surname>Handa</surname><given-names>H</given-names></name><name><surname>Suzukawa</surname><given-names>K</given-names></name><etal/></person-group><article-title>Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance</article-title><source>Clin Endocrinol (Oxf)</source><year>2006</year><volume>64</volume><issue>1</issue><fpage>12</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">16402923</pub-id></mixed-citation></ref><ref id="b14-vhrm-5-751"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oltmanns</surname><given-names>KM</given-names></name><name><surname>Gehring</surname><given-names>H</given-names></name><name><surname>Rudolf</surname><given-names>S</given-names></name><etal/></person-group><article-title>Hypoxia causes glucose intolerance in humans</article-title><source>Am J Respir Crit Care Med</source><year>2004</year><volume>169</volume><issue>11</issue><fpage>1231</fpage><lpage>1237</lpage><pub-id pub-id-type="pmid">15044204</pub-id></mixed-citation></ref><ref id="b15-vhrm-5-751"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tasali</surname><given-names>E</given-names></name><name><surname>Mokhlesi</surname><given-names>B</given-names></name><name><surname>Van Cauter</surname><given-names>E</given-names></name></person-group><article-title>Obstructive sleep apnea and type 2 diabetes: interacting epidemics</article-title><source>Chest</source><year>2008</year><volume>133</volume><issue>2</issue><fpage>496</fpage><lpage>506</lpage><pub-id pub-id-type="pmid">18252916</pub-id></mixed-citation></ref><ref id="b16-vhrm-5-751"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaw</surname><given-names>JE</given-names></name><name><surname>Punjabi</surname><given-names>NM</given-names></name><name><surname>Wilding</surname><given-names>JP</given-names></name><etal/></person-group><article-title>Sleep-disordered breathing and type 2 diabetes: a report from the International Diabetes Federation Taskforce on Epidemiology and Prevention</article-title><source>Diabetes Res Clin Pract</source><year>2008</year><volume>81</volume><issue>1</issue><fpage>2</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">18544448</pub-id></mixed-citation></ref><ref id="b17-vhrm-5-751"><label>17</label><mixed-citation publication-type="journal"><collab>International Expert Committee</collab><article-title>International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes</article-title><source>Diabetes Care</source><year>2009</year><volume>32</volume><issue>7</issue><fpage>1327</fpage><lpage>1334</lpage><pub-id pub-id-type="pmid">19502545</pub-id></mixed-citation></ref><ref id="b18-vhrm-5-751"><label>18</label><mixed-citation publication-type="book"><collab>American Academy of Sleep Medicine (AASM)</collab><source>International Classification of Sleep Disorders</source><publisher-loc>Westchester, IL</publisher-loc><publisher-name>AASM</publisher-name><year>2005</year></mixed-citation></ref><ref id="b19-vhrm-5-751"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stratton</surname><given-names>IM</given-names></name><name><surname>Adler</surname><given-names>AI</given-names></name><name><surname>Neil</surname><given-names>HA</given-names></name><etal/></person-group><article-title>Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study</article-title><source>BMJ</source><year>2000</year><volume>321</volume><issue>7258</issue><fpage>405</fpage><lpage>412</lpage><pub-id pub-id-type="pmid">10938048</pub-id></mixed-citation></ref><ref id="b20-vhrm-5-751"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Vegt</surname><given-names>F</given-names></name><name><surname>Dekker</surname><given-names>JM</given-names></name><name><surname>Ruhe</surname><given-names>HG</given-names></name><etal/></person-group><article-title>Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study</article-title><source>Diabetologia</source><year>1999</year><volume>42</volume><issue>8</issue><fpage>926</fpage><lpage>931</lpage><pub-id pub-id-type="pmid">10491751</pub-id></mixed-citation></ref><ref id="b21-vhrm-5-751"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khaw</surname><given-names>KT</given-names></name><name><surname>Wareham</surname><given-names>N</given-names></name><name><surname>Bingham</surname><given-names>S</given-names></name><name><surname>Luben</surname><given-names>R</given-names></name><name><surname>Welch</surname><given-names>A</given-names></name><name><surname>Day</surname><given-names>N</given-names></name></person-group><article-title>Asso- with cardiovascular disease and mortality in ciation of hemoglobin A<sub>1c</sub> adults: the European prospective investigation into cancer in Norfolk</article-title><source>Ann Intern Med</source><year>2004</year><volume>141</volume><issue>6</issue><fpage>413</fpage><lpage>420</lpage><pub-id pub-id-type="pmid">15381514</pub-id></mixed-citation></ref><ref id="b22-vhrm-5-751"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khaw</surname><given-names>KT</given-names></name><name><surname>Wareham</surname><given-names>N</given-names></name></person-group><article-title>Glycated hemoglobin as a marker of cardiovascular risk</article-title><source>Curr Opin Lipidol</source><year>2006</year><volume>17</volume><issue>6</issue><fpage>637</fpage><lpage>643</lpage><pub-id pub-id-type="pmid">17095908</pub-id></mixed-citation></ref><ref id="b23-vhrm-5-751"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thurnheer</surname><given-names>R</given-names></name></person-group><article-title>Obstructive sleep apnea and cardiovascular disease &#x02013; time to act!</article-title><source>Swiss Med Wkly</source><year>2007</year><volume>137</volume><issue>15&#x02013;16</issue><fpage>217</fpage><lpage>222</lpage><pub-id pub-id-type="pmid">17525876</pub-id></mixed-citation></ref><ref id="b24-vhrm-5-751"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edelman</surname><given-names>D</given-names></name><name><surname>Olsen</surname><given-names>MK</given-names></name><name><surname>Dudley</surname><given-names>TK</given-names></name><name><surname>Harris</surname><given-names>AC</given-names></name><name><surname>Oddone</surname><given-names>EZ</given-names></name></person-group><article-title>Utility of hemoglobin A<sub>1c</sub> in predicting diabetes risk</article-title><source>J Gen Intern Med</source><year>2004</year><volume>19</volume><issue>12</issue><fpage>1175</fpage><lpage>1180</lpage><pub-id pub-id-type="pmid">15610327</pub-id></mixed-citation></ref><ref id="b25-vhrm-5-751"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inoue</surname><given-names>K</given-names></name><name><surname>Matsumoto</surname><given-names>M</given-names></name><name><surname>Kobayashi</surname><given-names>Y</given-names></name></person-group><article-title>The combination of fasting plasma glucose and glycosylated hemoglobin predicts type 2 diabetes in Japanese workers</article-title><source>Diabetes Res Clin Pract</source><year>2007</year><volume>77</volume><issue>3</issue><fpage>451</fpage><lpage>458</lpage><pub-id pub-id-type="pmid">17346846</pub-id></mixed-citation></ref><ref id="b26-vhrm-5-751"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beks</surname><given-names>PH</given-names></name><name><surname>Mackaay</surname><given-names>AJ</given-names></name><name><surname>de Vries</surname><given-names>H</given-names></name><name><surname>de Neeling</surname><given-names>JN</given-names></name><name><surname>Bouter</surname><given-names>LM</given-names></name><name><surname>Heine</surname><given-names>RJ</given-names></name></person-group><article-title>Carotid artery stenosis is related to blood glucose level in an elderly Caucasian population: the Hoorn Study</article-title><source>Diabetologia</source><year>1997</year><volume>40</volume><issue>3</issue><fpage>290</fpage><lpage>298</lpage><pub-id pub-id-type="pmid">9084966</pub-id></mixed-citation></ref><ref id="b27-vhrm-5-751"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beks</surname><given-names>PJ</given-names></name><name><surname>Mackaay</surname><given-names>AJ</given-names></name><name><surname>de Neeling</surname><given-names>JN</given-names></name><name><surname>de Vries</surname><given-names>H</given-names></name><name><surname>Bouter</surname><given-names>LM</given-names></name><name><surname>Heine</surname><given-names>RJ</given-names></name></person-group><article-title>Peripheral arterial disease in relation to glycaemic level in an elderly Caucasian population: the Hoorn study</article-title><source>Diabetologia</source><year>1995</year><volume>38</volume><issue>1</issue><fpage>86</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">7744233</pub-id></mixed-citation></ref><ref id="b28-vhrm-5-751"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Premalatha</surname><given-names>G</given-names></name><name><surname>Shanthirani</surname><given-names>S</given-names></name><name><surname>Deepa</surname><given-names>R</given-names></name><name><surname>Markovitz</surname><given-names>J</given-names></name><name><surname>Mohan</surname><given-names>V</given-names></name></person-group><article-title>Prevalence and risk factors of peripheral vascular disease in a selected South Indian population: the Chennai Urban Population Study</article-title><source>Diabetes Care</source><year>2000</year><volume>23</volume><issue>9</issue><fpage>1295</fpage><lpage>1300</lpage><pub-id pub-id-type="pmid">10977021</pub-id></mixed-citation></ref><ref id="b29-vhrm-5-751"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>MA</given-names></name><name><surname>Kandala</surname><given-names>NB</given-names></name><name><surname>Kivimaki</surname><given-names>J</given-names></name><etal/></person-group><article-title>Gender differences in the cross-sectional relationships between sleep duration and markers of inflammation: Whitehall II Study</article-title><source>Sleep</source><year>2009</year><volume>32</volume><issue>7</issue><fpage>857</fpage><lpage>864</lpage><pub-id pub-id-type="pmid">19639748</pub-id></mixed-citation></ref></ref-list></back><floats-group><fig id="f1-vhrm-5-751" position="float"><label>Figure 1</label><caption><p>Correlations of HbA<sub>1c</sub> levels with AHI (<bold>A</bold>), AI (<bold>B</bold>), average SpO<sub>2</sub> (<bold>C</bold>) and percentage of sleep time with SpO<sub>2</sub>&#x0003c; 90% (<bold>D</bold>).</p><p><bold>Abbreviations:</bold> AHI, Apnea Hypopnea Index; AI, Arousal Index; HbA<sub>1c</sub>, glycosylated hemoglobin; SpO<sub>2</sub>, saturation of hemoglobin with oxygen as measured by pulse oximetry.</p></caption><graphic xlink:href="vhrm-5-751f1"/></fig><fig id="f2-vhrm-5-751" position="float"><label>Figure 2</label><caption><p>Correlations of fasting glucose levels with AHI (<bold>A</bold>), AI (<bold>B</bold>), average SpO<sub>2</sub> (<bold>C</bold>), and minimum SpO<sub>2</sub> (<bold>D</bold>).</p><p><bold>Abbreviations:</bold> AHI, Apnea Hypopnea Index; AI, Arousal Index; SpO<sub>2</sub>, saturation of hemoglobin with oxygen as measured by pulse oximetry.</p></caption><graphic xlink:href="vhrm-5-751f2"/></fig><table-wrap id="t1-vhrm-5-751" position="float"><label>Table 1</label><caption><p>Sleep and metabolic characteristics of OSAS patients</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Parameter</th><th align="left" rowspan="1" colspan="1">Mean &#x000b1;SD</th><th align="left" rowspan="1" colspan="1">Range</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">AHI (events/hour)</td><td align="left" rowspan="1" colspan="1">55.1 &#x000b1;26.4</td><td align="left" rowspan="1" colspan="1">15.2&#x02013;108</td></tr><tr><td align="left" rowspan="1" colspan="1">Average SpO<sub>2</sub> (%)</td><td align="left" rowspan="1" colspan="1">90 &#x000b1;5.7</td><td align="left" rowspan="1" colspan="1">72&#x02013;95</td></tr><tr><td align="left" rowspan="1" colspan="1">Minimum SpO<sub>2</sub> (%)</td><td align="left" rowspan="1" colspan="1">71.7 &#x000b1;12.1</td><td align="left" rowspan="1" colspan="1">41&#x02013;88</td></tr><tr><td align="left" rowspan="1" colspan="1">t &#x0003c; 90 (%)</td><td align="left" rowspan="1" colspan="1">31.39 &#x000b1;31.42</td><td align="left" rowspan="1" colspan="1">0&#x02013;99</td></tr><tr><td align="left" rowspan="1" colspan="1">AI (events/hour)</td><td align="left" rowspan="1" colspan="1">45.1 &#x000b1;23.3</td><td align="left" rowspan="1" colspan="1">5&#x02013;100</td></tr><tr><td align="left" rowspan="1" colspan="1">Sleep efficiency (%TST)</td><td align="left" rowspan="1" colspan="1">77.4 &#x000b1;14.4</td><td align="left" rowspan="1" colspan="1">34.4&#x02013;93.9</td></tr><tr><td align="left" rowspan="1" colspan="1">Sleep latency (minutes)</td><td align="left" rowspan="1" colspan="1">23.7 &#x000b1;15.1</td><td align="left" rowspan="1" colspan="1">5.5&#x02013;66.5</td></tr><tr><td align="left" rowspan="1" colspan="1">Stage 1 (%TST)</td><td align="left" rowspan="1" colspan="1">36.7 &#x000b1;16.4</td><td align="left" rowspan="1" colspan="1">9.4&#x02013;77.1</td></tr><tr><td align="left" rowspan="1" colspan="1">Stage 2 (%TST)</td><td align="left" rowspan="1" colspan="1">45.7 &#x000b1;10.4</td><td align="left" rowspan="1" colspan="1">25.8&#x02013;69.1</td></tr><tr><td align="left" rowspan="1" colspan="1">SWS (%TST)</td><td align="left" rowspan="1" colspan="1">8 &#x000b1;9.3</td><td align="left" rowspan="1" colspan="1">0&#x02013;38.2</td></tr><tr><td align="left" rowspan="1" colspan="1">REM (%TST)</td><td align="left" rowspan="1" colspan="1">12.4 &#x000b1;5.8</td><td align="left" rowspan="1" colspan="1">0&#x02013;24.4</td></tr><tr><td align="left" rowspan="1" colspan="1">Fasting glucose (mg/dl)</td><td align="left" rowspan="1" colspan="1">95.1 &#x000b1;12.5</td><td align="left" rowspan="1" colspan="1">67&#x02013;125</td></tr><tr><td align="left" rowspan="1" colspan="1">HbA<sub>1c</sub>(%)</td><td align="left" rowspan="1" colspan="1">5.2 &#x000b1;0.6</td><td align="left" rowspan="1" colspan="1">4.2&#x02013;6.3</td></tr></tbody></table><table-wrap-foot><fn id="tfn1-vhrm-5-751"><p><bold>Abbreviations:</bold> AHI, Apnea Hypopnea Index; AI, Arousal Index; HbA<sub>1c</sub>, glycosylated hemoglobin; OSAS, obstructive sleep apnea syndrome; REM, rapid eye motion; SD, standard deviation; SpO<sub>2</sub>, saturation of hemoglobin with oxygen as measured by pulse oximetry; SWS, slow-wave sleep; TST, total sleep time.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t2-vhrm-5-751" position="float"><label>Table 2</label><caption><p>Results of regression analysis</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1"/><th colspan="3" align="left" rowspan="1">Glucose levels<hr/></th></tr><tr><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">B &#x000b1; SD</th><th align="left" rowspan="1" colspan="1">Beta</th><th align="left" rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">BMI</td><td align="left" rowspan="1" colspan="1">0.640 &#x000b1;0.336</td><td align="left" rowspan="1" colspan="1">0.339</td><td align="left" rowspan="1" colspan="1">0.223</td></tr><tr><td align="left" rowspan="1" colspan="1">AHI</td><td align="left" rowspan="1" colspan="1">0.092 &#x000b1;0.095</td><td align="left" rowspan="1" colspan="1">0.195</td><td align="left" rowspan="1" colspan="1">0.340</td></tr><tr><td align="left" rowspan="1" colspan="1">AI</td><td align="left" rowspan="1" colspan="1">0.196 &#x000b1;0.094</td><td align="left" rowspan="1" colspan="1">0.365</td><td align="left" rowspan="1" colspan="1"><bold>0.047</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">t &#x0003c; 90</td><td align="left" rowspan="1" colspan="1">12.405 &#x000b1;7.176</td><td align="left" rowspan="1" colspan="1">0.312</td><td align="left" rowspan="1" colspan="1">0.095</td></tr><tr><td align="left" rowspan="1" colspan="1">Average SpO<sub>2</sub></td><td align="left" rowspan="1" colspan="1">&#x02212;0.973 &#x000b1;0.366</td><td align="left" rowspan="1" colspan="1">&#x02212;0.442</td><td align="left" rowspan="1" colspan="1"><bold>0.013</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Minimum SpO<sub>2</sub></td><td align="left" rowspan="1" colspan="1">&#x02212;0.419 &#x000b1;0.179</td><td align="left" rowspan="1" colspan="1">&#x02212;0.410</td><td align="left" rowspan="1" colspan="1"><bold>0.027</bold></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td colspan="3" align="left" rowspan="1"><bold>HbA</bold><bold>1c</bold><bold>levels</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">BMI</td><td align="left" rowspan="1" colspan="1">0.000 &#x000b1;0.016</td><td align="left" rowspan="1" colspan="1">0.006</td><td align="left" rowspan="1" colspan="1">0.976</td></tr><tr><td align="left" rowspan="1" colspan="1">AHI</td><td align="left" rowspan="1" colspan="1">0.011 &#x000b1;0.004</td><td align="left" rowspan="1" colspan="1">0.511</td><td align="left" rowspan="1" colspan="1"><bold>0.009</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">AI</td><td align="left" rowspan="1" colspan="1">0.011 &#x000b1;0.004</td><td align="left" rowspan="1" colspan="1">0.448</td><td align="left" rowspan="1" colspan="1"><bold>0.014</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">t &#x0003c; 90</td><td align="left" rowspan="1" colspan="1">0.877 &#x000b1;0.319</td><td align="left" rowspan="1" colspan="1">0.470</td><td align="left" rowspan="1" colspan="1"><bold>0.010</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Average SpO<sub>2</sub></td><td align="left" rowspan="1" colspan="1">&#x02212;0.470 &#x000b1;0.017</td><td align="left" rowspan="1" colspan="1">&#x02212;0.456</td><td align="left" rowspan="1" colspan="1"><bold>0.012</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Minimum SpO<sub>2</sub></td><td align="left" rowspan="1" colspan="1">&#x02212;0.015 &#x000b1;0.09</td><td align="left" rowspan="1" colspan="1">&#x02212;0.305</td><td align="left" rowspan="1" colspan="1">0.112</td></tr></tbody></table><table-wrap-foot><fn id="tfn2-vhrm-5-751"><p><bold>Abbreviations:</bold> AHI, Apnea Hypopnea Index; AI, Arousal Index; BMI, body mass index; SD, standard deviation; SpO<sub>2</sub>, saturation of hemoglobin with oxygen as measured by pulse oximetry.</p></fn></table-wrap-foot></table-wrap></floats-group></article>